Abstract
Newly Diagnosed Multiple Myeloma (MM) Patients Treated With Lenalidomide Induction and Maintenance Show a Low Incidence Of Second Primary Malignancies (SPMs)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have